BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

568 related articles for article (PubMed ID: 17454012)

  • 1. Hazardous alcohol consumption and other barriers to antiviral treatment among hepatitis C positive people receiving opioid maintenance treatment.
    Watson B; Conigrave KM; Wallace C; Whitfield JB; Wurst F; Haber PS
    Drug Alcohol Rev; 2007 May; 26(3):231-9. PubMed ID: 17454012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of mental and physical health disorders among older methadone patients.
    Rosen D; Smith ML; Reynolds CF
    Am J Geriatr Psychiatry; 2008 Jun; 16(6):488-97. PubMed ID: 18515693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment.
    Stenbacka M; Beck O; Leifman A; Romelsjö A; Helander A
    Drug Alcohol Rev; 2007 Jan; 26(1):55-63. PubMed ID: 17364837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiological survey of hepatitis C virus infection in a cohort of patients from a ser.T in naples, Italy.
    Curcio F; Villano G; Masucci S; Plenzik M; Veneruso C; De Rosa G
    J Addict Med; 2011 Mar; 5(1):43-9. PubMed ID: 21769046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of alcohol use among methadone maintenance patients by direct ethanol metabolites and self-reports.
    Wurst FM; Dürsteler-MacFarland KM; Auwaerter V; Ergovic S; Thon N; Yegles M; Halter C; Weinmann W; Wiesbeck GA
    Alcohol Clin Exp Res; 2008 Sep; 32(9):1552-7. PubMed ID: 18616663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Excessive alcohol consumption is associated with reduced quality of life among methadone patients.
    Senbanjo R; Wolff K; Marshall J
    Addiction; 2007 Feb; 102(2):257-63. PubMed ID: 17222280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knowledge of and interest in hepatitis C treatment at a methadone clinic.
    Walley AY; White MC; Kushel MB; Song YS; Tulsky JP
    J Subst Abuse Treat; 2005 Mar; 28(2):181-7. PubMed ID: 15780548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Access to care of patients with chronic hepatitis C virus infection in a university hospital: Is opioid dependence a limiting condition?
    Perut V; Labalette C; Sogni P; Ferrand I; Salmon-Céron D; Vidal-Trecan G
    Drug Alcohol Depend; 2009 Sep; 104(1-2):78-83. PubMed ID: 19464124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a brief instrument for routine outcome monitoring in opioid maintenance pharmacotherapy services: the brief treatment outcome measure (BTOM).
    Lawrinson P; Copeland J; Indig D
    Drug Alcohol Depend; 2005 Oct; 80(1):125-33. PubMed ID: 15869845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychopathological changes and quality of life in hepatitis C virus-infected, opioid-dependent patients during maintenance therapy.
    Schäfer A; Wittchen HU; Backmund M; Soyka M; Gölz J; Siegert J; Schäfer M; Tretter F; Kraus MR
    Addiction; 2009 Apr; 104(4):630-40. PubMed ID: 19335661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of successful chronic hepatitis C case finding among patients receiving opioid maintenance treatment in a primary care setting.
    Senn O; Seidenberg A; Rosemann T
    Addiction; 2009 Dec; 104(12):2033-8. PubMed ID: 19922570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addressing tri-morbidity (hepatitis C, psychiatric disorders, and substance use): the importance of routine mental health screening as a component of a comanagement model of care.
    Fireman M; Indest DW; Blackwell A; Whitehead AJ; Hauser P
    Clin Infect Dis; 2005 Apr; 40 Suppl 5():S286-91. PubMed ID: 15768336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Zopiclone misuse: an update from Dublin.
    Bannan N; Rooney S; O'connor J
    Drug Alcohol Rev; 2007 Jan; 26(1):83-5. PubMed ID: 17364840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C treatment of opioid dependants receiving maintenance treatment: results of a Norwegian pilot study.
    Krook AL; Stokka D; Heger B; Nygaard E
    Eur Addict Res; 2007; 13(4):216-21. PubMed ID: 17851243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depression in methadone maintenance treatment patients: rate and risk factors.
    Peles E; Schreiber S; Naumovsky Y; Adelson M
    J Affect Disord; 2007 Apr; 99(1-3):213-20. PubMed ID: 17055063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of hepatitis B and C infection in a methadone clinic population: implications for hepatitis B vaccination.
    Carter H; Robinson G; Hanlon C; Hailwood C; Massarotto A
    N Z Med J; 2001 Jul; 114(1136):324-6. PubMed ID: 11548096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of buprenorphine maintenance in office-based practice.
    Magura S; Lee SJ; Salsitz EA; Kolodny A; Whitley SD; Taubes T; Seewald R; Joseph H; Kayman DJ; Fong C; Marsch LA; Rosenblum A
    J Addict Dis; 2007; 26(2):13-23. PubMed ID: 17594994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience of hepatitis C among current or former heroin users attending general practice.
    Cullen W; Kelly Y; Stanley J; Langton D; Bury G
    Ir Med J; 2005 Mar; 98(3):73-4. PubMed ID: 15869062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescription opioid abuse among enrollees into methadone maintenance treatment.
    Rosenblum A; Parrino M; Schnoll SH; Fong C; Maxwell C; Cleland CM; Magura S; Haddox JD
    Drug Alcohol Depend; 2007 Sep; 90(1):64-71. PubMed ID: 17386981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of an integrated cognitive behaviour therapy (CBT) treatment program for co-occurring depression and substance misuse in young people.
    Hides L; Carroll S; Catania L; Cotton SM; Baker A; Scaffidi A; Lubman DI
    J Affect Disord; 2010 Feb; 121(1-2):169-74. PubMed ID: 19604584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.